See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2023_Surgery_Partners_Inc.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.469749868477689, 'aggregate_val': 2217400000, 'exp_sum': 4181800000, 'exp_to_value': {'LaborExpense': 746400000, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 102200000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 1964400000, 'DepreciationDepletionAndAmortization': 114800000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 1254000000}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc.
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 4,179,400,000 |
1 | AssetsNonCurrent | 423,300,000 |
2 | AssetsCurrent | 921,000,000 |
3 | PropertyPlantAndEquipment | 876,600,000 |
4 | remainder_Assets | 281,800,000 |
5 | LongTermLiabilities | 0 |
6 | LiabilitiesCurrent | 493,400,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 746,400,000 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 102,200,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 1,964,400,000 |
13 | DepreciationDepletionAndAmortization | 114,800,000 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 0 |
16 | remainder_Expenses | -710,400,000 |
17 | remainder_Revenues | 2,539,300,000 |
18 | remainder_NetIncome | -234,900,000 |
19 | remainder_ComprehensiveNetIncome | -33,900,000 |
yvar | yval | |
---|---|---|
0 | Assets | 6,682,100,000 |
1 | Liabilities | 493,400,000 |
2 | Expenses | 2,217,400,000 |
3 | Revenues | 2,539,300,000 |
4 | StockholdersEquity | 6,188,700,000 |
5 | NetIncome | 87,000,000 |
6 | ComprehensiveNetIncome | 53,100,000 |
7 | BaseVar | 6,929,707,500 |
8 | EconomicCapitalRatio | 2.93 |